Donald Trump’s push to bring down drug prices in the US has rattled the world’s leading pharmaceutical companies. Now, they’re confronting a new menace as Germany seeks to plug a ballooning deficit in its public health-insurance funds.
www.bloomberg.com
#Germanys #Healthcare #Reforms #Herald #Pain #Big #Pharma
Germany’s Healthcare Reforms Herald More Pain for Big Pharma
